Zimmer Biomet Holdings, Inc. ZBH, a global leader in musculoskeletal healthcare, recently launched PrimaGen Advanced Allograft. The product, which falls under its spine segment, has been designed to ...
AMSTERDAM, The Netherlands, April 25 /PRNewswire/ -- Primagen Holding BV, a molecular diagnostics company, announced today that the exclusive, worldwide license for the CD133 diagnostic biomarker has ...
Primagen Holding BV has announced that the U.S. Patent and Trademark Office has granted a patent for its Mitox™ mitochondrial DNA quantification technology as biomarkers for efficacy and adverse ...
Primagen Holding BV will exhibit its products in booth #4463 at the American Society of Clinical Oncology (ASCO) meeting being held in Atlanta, Georgia, from June 2-6, after introducing its Cancer ...
Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced the launch of PrimaGen Advanced Allograft, an autograft substitute containing the same bone healing elements as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results